Patterns of colorectal cancer care in the United States and Canada: A systematic review

Journal of the National Cancer Institute - Monographs

Volumn , Issue 46, 2013, Pages 13-35

  Butler, Eboneé N ^a   Chawla, Neetu ^a   Lund, Jennifer ^b   Harlan, Linda C ^a   Warren, Joan L ^c   Yabroff, K Robin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b IL   (United States)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANADA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; COLORECTAL CANCER; HUMAN; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TERMINAL CARE; UNITED STATES; COLORECTAL TUMOR; COMPARATIVE STUDY; HEALTH CARE QUALITY; REVIEW; SURVIVAL; COLORECTAL NEOPLASMS;

CANADA; COLORECTAL NEOPLASMS; HUMANS; QUALITY OF HEALTH CARE; SURVIVAL ANALYSIS; TERMINAL CARE; UNITED STATES;

EID: 84882998730     PISSN: 10526773     EISSN: 17456614     Source Type: Book Series    
DOI: 10.1093/jncimonographs/lgt007     Document Type: Article

References (92)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010. http://globocan.iarc.fr. Accessed June 7, 2013.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 [published online ahead of print January 13, 2012]. CA Cancer J Clin. 2012;62(1):10-29. doi:10.3322/caac.20138.
3. Canadian Cancer Society's Steering Committee on Cancer Statistics. Canadian Cancer Statistics 2011. Toronto, ON: Canadian Cancer Society; 2011.
4. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates [published online ahead of print December 10, 2009]. Cancer. 2010;116(3):544-573. doi:10.1002/cncr.24760.
5. Phillips KA, Liang SY, Ladabaum U, et al. Trends in colonoscopy for colorectal cancer screening [published online ahead of print January 17, 2007]. Med Care. 2007;45(2):160-167. doi:10.1002/cncr.24760.
6. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [published online ahead of print June 4, 2004]. N Engl J Med. 2004;350(23):2335-2342. doi:10.1056/NEJMoa032691.
7. Schrag D. The price tag on progress-chemotherapy for colorectal cancer [published online ahead of print July 23, 2004]. N Engl J Med. 2004;351(4):317-319. doi:0.1056/NEJMp048143.
8. Chawla N, Butler EN, Lund J, Warren JL, Harlan LC, YabroffKR. Patterns of care in Europe, Australia, and New Zealand. J Natl Cancer Inst Monogr. 2013;46(1):36-61.
9. Hardiman KM, Cone M, Sheppard BC, Herzig DO. Disparities in the treatment of colon cancer in octogenarians [published online ahead of print April 28, 2009]. Am J Surg. 2009;197(5):624-628. doi:10.1016/j. amjsurg.2008.12.018.
10. Pisu M, Richardson LC, Kim YI, et al. Less-than-standard treatment in rectal cancer patients: which patients are at risk [published online ahead of print April 2, 2010]? J Natl Med Assoc. 2010;102(3):190-198.
11. Ricciardi R, Roberts PL, Read TE, Marcello PW, Schoetz DJ, Baxter NN. Variability in reconstructive procedures following rectal cancer surgery in the United States [published online ahead of print May 21, 2010]. Dis Colon Rectum. 2010;53(6):874-880. doi:10.1007/DCR.0b013e3181cf6f58.
12. Latosinsky S, Turner D. Local recurrence after rectal cancer treatment in Manitoba [published online ahead of print February 2, 2009]. Can J Surg. 2009;52(1):45-50.
13. Demers AA, Latosinsky S, Turner D. Survival and treatment trends of rectal cancer patients in a population with suboptimal local control [published online ahead of print November 6, 2007]. Eur J Surg Oncol. 2008;34(6):655-661. doi:10.1016/j.ejso.2007.09.002.
14. Esnaola NF, Stewart AK, Feig BW, Skibber JM, Rodriguez-Bigas MA. Age-, race-, and ethnicity-related differences in the treatment of nonmetastatic rectal cancer: a patterns of care study from the national cancer data base [published online ahead of print August 21, 2008]. Ann Surg Oncol. 2008;15(11):3036-3047. doi:10.1245/s10434-008-0106-9.
15. Chang GJ, Skibber JM, Feig BW, Rodriguez-Bigas M. Are we undertreating rectal cancer in the elderly? An epidemiologic study [published online ahead of print August 2, 2007]. Ann Surg. 2007;246(2):215-221. doi:10.1097/SLA.0b013e318070838f.
16. Ricciardi R, Virnig BA, MadoffRD, Rothenberger DA, Baxter NN. The status of radical proctectomy and sphincter-sparing surgery in the United States [published online ahead of print June 19, 2007]. Dis Colon Rectum. 2007;50(8):1119-1127; discussion 1126-1127. doi:10.1007/s10350-007-0250-5.
17. Morris AM, Wei Y, Birkmeyer NJ, Birkmeyer JD. Racial disparities in late survival after rectal cancer surgery [published online ahead of print November 25, 2006]. J Am Coll Surg. 2006;203(6):787-794. doi:10.1016/j. jamcollsurg.2006.08.005.
18. Purves H, Pietrobon R, Hervey S, Guller U, Miller W, Ludwig K. Relationship between surgeon caseload and sphincter preservation in patients with rectal cancer [published online ahead of print April 7, 2005]. Dis Colon Rectum. 2005;48(2):195-202; discussion 202-204. doi:10.1007/s10350-004-0793-7.
19. Morris AM, Billingsley KG, Baxter NN, Baldwin LM. Racial disparities in rectal cancer treatment: a population-based analysis [published online ahead of print February 11, 2004]. Arch Surg. 2004;139(2):151-155; discussion 6. doi:10.1001/archsurg.139.2.151.
20. Phang PT, MacFarlane JK, Taylor RH, et al. Practice patterns and appropriateness of rectal cancer management in British Columbia. BC Med J. 2003;45(7):324-329.
21. Schroen AT, Cress RD. Use of surgical procedures and adjuvant therapy in rectal cancer treatment: a population-based study [published online ahead of print October 31, 2001]. Ann Surg. 2001;234(5):641-651.
22. Chan TW, Brown C, Ho CC, Gill S. Primary tumor resection in patients presenting with metastatic colorectal cancer: analysis of a provincial population- based cohort [published online ahead of print August 26, 2009]. Am J Clin Oncol. 2010;33(1):52-55. doi:10.1097/COC.0b013e31819e902d.
23. Diggs JC, Xu F, Diaz M, Cooper GS, Koroukian SM. Failure to screen: predictors and burden of emergency colorectal cancer resection[published online ahead of print March 6, 2007]. Am J Manag Care. 2007;13(3):157-164.
24. Cook AD, Single R, McCahill LE. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000 [published online ahead of print June 21, 2005]. Ann Surg Oncol. 2005;12(8):637-345. doi:10.1245/ASO.2005.06.012.
25. Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D. Use of surgery among elderly patients with stage IV colorectal cancer [published online ahead of print September 1, 2004]. J Clin Oncol. 2004;22(17):3475-3484. doi:10.1200/JCO.2004.10.218.
26. Wudel LJ Jr, Chapman WC, Shyr Y, et al. Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival [published online ahead of print May 2, 2002]. Arch Surg. 2002;137(5):550-554; discussion 554-556.
27. Roetzheim RG, Pal N, Gonzalez EC, Ferrante JM, Van Durme DJ, Krischer JP. Effects of health insurance and race on colorectal cancer treatments and outcomes [published online ahead of print November 15, 2000]. Am J Public Health. 2000;90(11):1746-1754.
28. Simunovic M, To T, Baxter N, et al. Hospital procedure volume and teaching status do not influence treatment and outcome measures of rectal cancer surgery in a large general population [published online ahead of print April 18, 2000]. J Gastrointest Surg. 2000;4(3):324-330.
29. Dunn EF, Kozak KR, Moody JS. External beam radiotherapy for colon cancer: patterns of care [published online ahead of print July 22, 2009]. Int J Radiat Oncol Biol Phys. 2010;76(5):1420-1424. doi:10.1016/j. ijrobp.2009.03.014.
30. Kuo I, Wong JH, Roy-Chowdhury S, Lum SS, Morgan JW, Kazanjian K. The use of pelvic radiation in stage II rectal cancer: a population-based analysis [published online ahead of print October 26, 2010]. Am Surg. 2010;76(10):1092-1095.
31. Lin C, Charlton ME, Meza JL, Enke CA, Loberiza FR Jr. Temporal and regional variations in the use of preoperative radiation therapy for rectal cancer [published online ahead of print December 3, 2009]. Am J Clin Oncol. 2010;33(5):443-447. doi:10.1097/COC.0b013e3181b4b175.
32. Romanus D, Weiser MR, Skibber JM, et al. Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysis [published online ahead of print September 17, 2009]. J Natl Compr Canc Netw. 2009;7(8):895-904.
33. Dobie SA, Warren JL, Matthews B, Schwartz D, Baldwin LM, Billingsley K. Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population [published online ahead of print January 15, 2008]. Cancer. 2008;112(4):789-799. doi:10.1002/cncr.23244.
34. Morris AM, Billingsley KG, Hayanga AJ, Matthews B, Baldwin LM, Birkmeyer JD. Residual treatment disparities after oncology referral for rectal cancer [published online ahead of print May 15, 2008]. J Natl Cancer Inst. 2008;100(10):738-744. doi:10.1093/jnci/djn145.
35. Baxter NN, Rothenberger DA, Morris AM, Bullard KM. Adjuvant radiation for rectal cancer: do we measure up to the standard of care? An epidemiologic analysis of trends over 25 years in the United States [published online ahead of print February 5, 2005]. Dis Colon Rectum. 2005;48(1):9-15. doi:10.1007/s10350-004-0792-8.
36. Neugut AI, Fleischauer AT, Sundararajan V, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study [published online ahead of print June 1, 2002]. J Clin Oncol. 2002;20(11):2643-2650.
37. Schrag D, Gelfand SE, Bach PB, Guillem J, Minsky BD, Begg CB. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results-Medicare [published online ahead of print September 5, 2001]. J Clin Oncol. 2001;19(17):3712-3718.
38. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort [published online ahead of print March 29, 2003]. J Clin Oncol. 2003;21(7):1293-1300. doi:10.1200/JCO.2003.06.178.
39. Kirkpatrick HM, Aitelli CL, Qin H, Becerra C, Lichliter WE, McCollum AD. Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer [published online ahead of print July 21, 2010]. Clin Colorectal Cancer. 2010;9(3):150-156. doi:10.3816/CCC.2010.n.020.
40. Winget M, Hossain S, Yasui Y, Scarfe A. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment [published online ahead of print June 26, 2010]. Cancer. 2010;116(20):4849-4856. doi:10.1002/cncr.25250.
41. Earle CC, Weiser MR, Ter Veer A, et al. Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer [published online ahead of print August 22, 2009]. J Surg Oncol. 2009;100(7):525-528. doi:10.1002/jso.21373.
42. Hershman DL, Buono DL, Malin J, McBride R, Tsai WY, Neugut AI. Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer [published online ahead of print November 12, 2009]. J Natl Cancer Inst. 2009;101(23):1633-41. doi:10.1093/jnci/djp387.
43. Wirtzfeld DA, Mikula L, Gryfe R, et al. Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces [published online ahead of print April 29, 2009]. Can J Surg. 2009;52(2):92-97.
44. Bradley CJ, Given CW, Dahman B, Fitzgerald TL. Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer [published online ahead of print March 12, 2008]. Arch Intern Med. 2008;168(5):521-529. doi:10.1001/archinternmed.2007.82.
45. Quah HM, Joseph R, Schrag D, et al. Young age influences treatment but not outcome of colon cancer [published online ahead of print June 27, 2007]. Ann Surg Oncol. 2007;14(10):2759-2765. doi:10.1245/s10434-007-9465-x.
46. Dobie SA, Baldwin LM, Dominitz JA, Matthews B, Billingsley K, Barlow W. Completion of therapy by Medicare patients with stage III colon cancer [published online ahead of print May 4, 2006]. J Natl Cancer Inst. 2006;98(9):610-619. doi:10.1093/jnci/djj159.
47. Luo R, Giordano SH, Freeman JL, Zhang D, Goodwin JS. Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer [published online ahead of print October 13, 2006]. Oncologist. 2006;11(9):1025-1033. doi:10.1634/theoncologist.11-9-1025.
48. McGory ML, Zingmond DS, Sekeris E, Bastani R, Ko CY. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer [published online ahead of print February 14, 2006]. Dis Colon Rectum. 2006;49(3):319-329. doi:10.1007/s10350-005-0283-6.
49. Neugut AI, Matasar M, Wang X, et al. Duration of adjuvant chemotherapy for colon cancer and survival among the elderly [published online ahead of print April 19, 2006]. J Clin Oncol. 2006; 24(15):2368-2375. doi:10.1200/JCO.2005.04.5005.
50. Baldwin LM, Dobie SA, Billingsley K, et al. Explaining black-white differences in receipt of recommended colon cancer treatment [published online ahead of print August 18, 2005]. J Natl Cancer Inst. 2005;97(16):1211-1220. doi:10.1093/jnci/dji241.
51. Jessup JM, Stewart A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation [published online ahead of print December 8, 2005]. J Natl Med Assoc. 2005;294(21):2703-2711. doi:10.1001/jama.294.21.2703.
52. Keating NL, Landrum MB, Meara E, Ganz PA, Guadagnoli E. Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector? [published online ahead of print February 17, 2005]. J Natl Cancer Inst. 2005;97(4):257-264. doi:10.1093/jnci/dji044.
53. Wu X, Chen VW, Andrews PA, Chen L, Hsieh M, Fontham ET. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana [published online ahead of print November 24, 2004]. J La State Med Soc. 2004;156(5):255-261.
54. Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF, Neugut AI. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer [published online ahead of print March 5, 2002]. Ann Intern Med. 2002;136(5):349-357.
55. Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer [published online ahead of print June 8, 2001]. J Natl Cancer Inst. 2001;93(11):850-857.
56. Sundararajan V, Grann VR, Jacobson JS, Ahsan H, Neugut AI. Variations in the use of adjuvant chemotherapy for node-positive colon cancer in theelderly: a population-based study [published online ahead of print June 23, 2001]. Cancer. 2001;7(3):213-218.
57. Hendren S, Birkmeyer JD, Yin H, Banerjee M, Sonnenday C, Morris AM. Surgical complications are associated with omission of chemotherapy for stage III colorectal cancer [published online ahead of print December 24, 2010]. Dis Colon Rectum. 2010;53(12):1587-1593. doi:10.1007/DCR.0b013e3181f2f202.
58. Oliveria SA, Yood MU, Campbell UB, Yood SM, Stang P. Treatment and referral patterns for colorectal cancer [published online ahead of print August 21, 2004]. Med Care. 2004;42(9):901-906.
59. Cree M, Tonita J, Turner D, et al. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004 [published online ahead of print July 28, 2009]. Clin Colorectal Cancer. 2009;8(3):141-145. doi:10.3816/CCC.2009.n.023.
60. Cronin DP, Harlan LC, Potosky AL, Clegg LX, Stevens JL, Mooney MM. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer [published online ahead of print October 13, 2006]. Am J Gastroenterol. 2006;101(10):2308-2318. doi:10.1111/j.1572-0241.2006.00775.x.
61. VanEenwyk J, Campo JS, Ossiander EM. Socioeconomic and demographic disparities in treatment for carcinomas of the colon and rectum [published online ahead of print July 13, 2002]. Cancer. 2002;95(1):39-46. doi:10.1002/cncr.10645.
62. Dharma-Wardene MW, de Gara C, Au HJ, Hanson J, Hatcher J. Ageism in rectal carcinoma? Treatment and outcome variations [published online ahead of print June 10, 2003]. Int J Gastrointest Cancer. 2002;32(2-3):129-138. doi:10.1385/IJGC:32:2-3:129.
63. White A, Liu CC, Xia R, et al. Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002 [published online ahead of print October 22, 2008]. Cancer. 2008;113(12):3400-3409. doi:10.1002/cncr.23924.
64. Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer [published online ahead of print March 1, 2002]. J Clin Oncol. 2002;20(5):1192-1202.
65. Cheung WY, Pond GR, Rother M, et al. Adherence to surveillance guidelines after curative resection for stage II/III colorectal cancer [published online ahead of print July 16, 2008]. Clin Colorectal Cancer. 2008;7(3):191-196. doi:10.3816/CCC.2008.n.025.
66. Cooper GS, Kou TD, Reynolds HL Jr. Receipt of guideline-recommended follow-up in older colorectal cancer survivors: a population-based analysis [published online ahead of print September 10, 2008]. Cancer. 2008;113(8):2029-2037. doi:10.1002/cncr.23823.
67. Cooper GS, Payes JD. Temporal trends in colorectal procedure use after colorectal cancer resection [published online ahead of print December 5, 2006]. Gastrointest Endosc. 2006;64(6):933-940. doi:10.1016/j. gie.2006.08.024.
68. Cooper GS, Yuan Z, Chak A, Rimm AA. Patterns of endoscopic follow-up after surgery for nonmetastatic colorectal cancer [published online ahead of print July 7, 2007]. Gastrointest Endosc. 2000;52(1):33-38. doi:10.1067/mge.2000.106685.
69. Ellison GL, Warren JL, Knopf KB, Brown ML. Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery [published online ahead of print January 1, 2004]. Health Serv Res. 2003;38(6 pt 2):1885-1903. doi:10.1111/j.1475-6773.2003.00207.x
70. Elston Lafata J, Cole Johnson C, Ben-Menachem T, Morlock RJ. Sociodemographic differences in the receipt of colorectal cancer surveillance care following treatment with curative intent [published online ahead of print May 1, 2001]. Med Care. 2001;39(4):361-372.
71. Emanuel EJ, Young-Xu Y, Levinsky NG, Gazelle G, Saynina O, Ash AS. Chemotherapy use among Medicare beneficiaries at the end of life [published online ahead of print April 16, 2003]. Ann Intern Med. 2003;138(8):639-643.
72. Hilsden RJ, Bryant HE, Sutherland LR, Brasher PM, Fields AL. A retrospective study on the use of post-operative colonoscopy following potentially curative surgery for colorectal cancer in a Canadian province [published online ahead of print April 21, 2004]. BMC Cancer. 2004;4:14. doi:10.1186/1471-2407-4-14.
73. Keating NL, Landrum MB, Lamont EB, Earle CC, Bozeman SR, McNeil BJ. End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector [published online ahead of print June 22, 2009]. Cancer. 2010;116(15):3732-3739. doi:10.1002/cncr.25077.
74. Knopf KB, Warren JL, Feuer EJ, Brown ML. Bowel surveillance patterns after a diagnosis of colorectal cancer in Medicare beneficiaries [published online ahead of print October 26, 2001]. Gastrointest Endosc. 2001;54(5):563-571.
75. Lang K, Lines LM, Lee DW, Korn JR, Earle CC, Menzin J. Trends in healthcare utilization among older Americans with colorectal cancer: a retrospective database analysis [published online ahead of print December 17, 2009]. BMC Health Serv Res. 2009;9:227. doi:10.1186/1472-6963-9-227.
76. McCarthy EP, Phillips RS, Zhong Z, Drews RE, Lynn J. Dying with cancer: patients' function, symptoms, and care preferences as death approaches [published online ahead of print May 16, 2000]. J Am Geriatr Soc. 2000;48(5 suppl):S110-S121.
77. Rolnick S, Hensley Alford S, Kucera GP, et al. Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer [published online ahead of print November 17, 2005]. J Natl Cancer Inst Monogr. 2005;(35):96-101. doi:10.1093/jncimonographs/lgi045.
78. Rulyak SJ, Mandelson MT, Brentnall TA, Rutter CM, Wagner EH. Clinical and sociodemographic factors associated with colon surveillance among patients with a history of colorectal cancer [published online ahead of print January 28, 2004]. Gastrointest Endosc. 2004;59(2):239-247.
79. Salz T, Weinberger M, Ayanian JZ, et al. Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States [published online ahead of print September 3, 2010]. BMC Health Serv Res. 2010;10:256. doi:10.1186/1472-6963-10-256.
80. Shugarman LR, Bird CE, Schuster CR, Lynn J. Age and gender differences in Medicare expenditures at the end of life for colorectal cancer decedents [published online ahead of print March 29, 2007]. J Womens Health (Larchmt). 2007;16(2):214-227. doi:10.1089/jwh.2006.0012.
81. Snyder CF, Earle CC, Herbert RJ, Neville BA, Blackford AL, Frick KD. Trends in follow-up and preventive care for colorectal cancer survivors [published online ahead of print January 17, 2008]. J Gen Intern Med. 2008;23(3):254-259. doi:10.1007/s11606-007-0497-5.
82. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials [published online ahead of print October 31, 2001]. Lancet. 2001;358(9290):1291-1304. doi:10.1016/S0140-6736(01)06409-1.
83. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population [published online ahead of print August 21, 2002]. Med Care. 2002;40(8 suppl):3-18, iv. doi:10.1097/01. MLR.0000020942.47004.03.
84. Wagman R, Minsky BD, Cohen AM, Guillem JG, Paty PP. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up [published online ahead of print September 25, 1998]. Int J Radiat Oncol Biol Phys. 1998;42(1):51-57.
85. National Institutes of Health. Adjuvant therapy for patients with colon and rectal cancer [published online ahead of print September 19, 1990]. J Natl Med Assoc. 1990;264(11):1444-1450.
86. Elkin EB, Bach PB. Cancer's next frontier: addressing high and increasing costs [published online ahead of print March 18, 2010]. J Natl Med Assoc. 2010;303(11):1086-1087. doi:10.1001/jama.2010.283.
87. Du XL, Lairson DR, Begley CE, Fang S. Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort [published online ahead of print November 30, 2005]. J Clin Oncol. 2005;23(34):8620-8628. doi:10.1200/JCO.2005.02.6252.
88. Howlader NA, Krapcho M, Neyman N, et al., eds. SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute; 2011. http://seer.cancer.gov/csr/1975_2008.
89. Boscoe FP, Schrag D, Chen K, Roohan PJ, Schymura MJ. Building capacity to assess cancer care in the Medicaid population in New YorkState [published ahead of print December 17, 2010]. Health Serv Res. 2011;46(3):805-820. doi:10.1111/j.1475-6773.2010.01221.x.
90. Bradley CJ, Given CW, Luo Z, Roberts C, Copeland G, Virnig BA. Medicaid, Medicare, and the Michigan Tumor Registry: a linkage strategy [published online ahead of print July 21, 2007]. Med Decis Making. 2007;27(4):352-363. doi:10.1177/0272989X07302129.
91. Lipscomb J, Gillespie TW. State-level cancer quality assessment and research: building and sustaining the data infrastructure [published online ahead of print July 30, 2007]. Cancer. 2011;17(4):246-256. doi:10.1097/PPO.0b013e3182296422.
92. Canadian Partnership Against Cancer Web site. http://www.partnershipagainstcancer.ca/. Accessed June 7, 2013.